This is a review of China's key developments during H2 2022 in antitrust, civil law, corporate, data and cybersecurity, foreign investment and medical treatment including China’s Supreme Court proposed revisions to civil litigation rules under the Anti Monopoly Law.
As China Rolled Out Its COVID-19 Shots, Victims of Earlier Vaccine Scandals Vanished thediplomat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thediplomat.com Daily Mail and Mail on Sunday newspapers.
Dear Shareholders, On behalf of the board ( Board ) of directors ( Directors ) of Austar Lifesciences Limited ( Company ), I am pleased to present the annual report of the Company and its subsidiaries (collectively as the Group or AUSTAR ) for the year ended 31 December 2020 ( Year ). The year 2020 has been a challenging year for any individual, company and organization under the impact of the COVID-19 pandemic and its consequential policies. From a global perspective, the pandemic has not been slowing down even though China s pandemic conditions had become far stable and under extraordinary control. Under such conditions, the Group has been reacting, responding and acting during such extraordinary moments. Our colleagues could never have believed they were able to deliver our critical utilities and bioprocess systems to our COVID-19 vaccine manufacturer clients within 3 months from order to completion of installation and commissioning with construc
MAJOR MARKET COMPARISON OF KEY COVID-19 LEGISLATION
As pharmaceutical companies worldwide race to supply vaccines
and therapeutics to fight the spread of COVID-19, understanding the
laws and regulations that could impact parties involved in the
COVID-19 pandemic supply chain is increasingly important. This
article provides an overview and comparison of legislation relevant
to manufacturers, suppliers, distributors, and health professionals
involved in the response to the COVID-19 pandemic in each of the
United States ( US ), European Union ( EU ),
United Kingdom ( UK ), and People s Republic of China
( PRC ), including measures to ensure (1) immunity from
COVID-19 countermeasure liability; (2) government ability to direct
(or redirect) resources; (3) emergency use authorizations; (4)
Coveted COVID-19 Chinese vaccines provoke social media scams, scalpers targeting overseas Chinese
By GT staff reporters Source: Global Times Published: 2020/12/14 20:08:42
A vaccine factory in China Photo: AFP I can secure you a dose of Sinopharm with a very competitive price of 3,000 yuan ($458) for two doses, getting injected in a first-class public hospital in Beijing. Many like you have approached me asking for quick accessibility, and no one reported any serious adverse reaction so far, Xiao said when peddling COVID-19 vaccines via WeChat to a Global Times reporter who pretended to be a student going abroad and desperate for vaccine.
Xiao, who declined to tell the reporter her full name as many of her peers, is one of many vaccine scalpers lurking in the social media circles of Chinese students planning to study abroad, selling her business opportunities.